Total artificial hearts: Bridge to transplantation

Cardiology Clinics

Volumn 21, Issue 1, 2003, Pages 101-113

  Copeland, Jack G ^a   Arabia, Francisco A ^a   Tsau, Pei H ^a   Nolan, Paul E ^a   McClellan, Douglas ^a   Smith, Richard G ^a   Slepian, Marvin J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART; BIOMEDICAL TECHNOLOGY ASSESSMENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; TREATMENT INDICATION;

EID: 0038247924     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(02)00136-4     Document Type: Review

References (31)

1. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-stage cardiac replacement. Am J Cardiol 1969;24(5):723-30.
2. Cooley DA, Akutsu T, Norman JC, Serrato MA, Frazier OH. Total artificial heart in two-staged cardiac transplantation. Cardiovas Dis Bull Texas Heart Inst 1981;8(3):305-19.
3. DeVries WC, Anderson JH, Joyce LD, Anderson FL, Hammond EH, Jarvik RK, et al. Clinical use of the total artificial heart. N Engl J Med 1984;310(5):273-8.
4. Copeland JG, Levinson MM, Smith R, Icenogle TB, Vaughn C, Cheng K, et al. The total artificial heart as a bridge to transplantation. A report of two cases. JAMA 1986;256(21):2991-5.
5. Copeland JG, Smith RG, Cleavinger MR. Development and current status of the CardioWest C-70® (Jarvik-7) total artificial heart. In: Lewis T, Graham TR, editors. Mechanical circulatory support. Great Britain: Edward Arnold; 1995. p. 186-98.
6. Kolff WJ, DeVries WC, Joyce LD, Olsen DB, Jarvik RK, Nielsen S, et al. Lessons learned from Dr. Barney Clark in the first patient with an artificial heart. Int J Artif Organs 1983;1:165-74.
7. Johnson KE, Prieto M, Joyce LD, Pritzker M, Emery RW. Summary of the clinical use of the Symbion total artificial heart: a registry report. J Heart Lung Transplant 1992;11(1):103-16.
8. Szefner J, Cabrol C. Control and treatment of hemostasis in patients with a total artificial heart: the experience at La Pitie. In: Piffare R, editors. Anticoagulation, hemostasis, and blood preservation in cardiovascular surgery. Philadelphia: Hanley and Belfus; 1993. p. 237-64.
9. Copeland JG, Pavie A, Duveau D, Keon WJ, Masters R, Pifarre R, et al. Bridge to transplant with the CardioWest total artificial heart: the international experience 1993 to 1995. J Heart Lung Transplant 1996;15(1):94-9.
10. Copeland JG, Arabia FA, Banchy ME, Sethi GK, Foy B, Long J, et al. The CardioWest total artificial heart bridge to transplantation: 1993 to 1996 national trial. Ann Thorac Surg 1998;66:1662-9.
11. Copeland JG, Arabia FA, Smith RG, Sethi GK, Nolan PE, Banchy ME. Arizona Experience with CardioWest total artificial heart bridge to transplantation. Ann Thorac Surg 1999;68(2):756-60.
12. Leprince P, Pavie A, Bonnet N, Leger P, Gandjbakhch I. Fifteen years single center experience with the total artificial heart Jarvik-7:a bridge to the new era of electrical total artificial heart. J Heart Lung Transplant 2002;21(1):106.
13. Arabia FA, Copeland JG, Pavie A, Smith RG. Implantation technique for the CardioWest total artificial heart. Ann Thorac Surg 1999;68(2):698-704.
14. Copeland JG, Arabia FA, Smith RG, Covington D. Synthetic membrane neo-pericardium facilitates total artificial heart explantation. J Heart Lung Transplant 2001;20(6):654-6.
15. Copeland JG, Smith RG, Arabia FA, Nolan PE, Mehta VK, McCarthy MS, Chisholm KA. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system and the Thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg 2001;71(Suppl 3):S92-7.
16. Traverso CI, Caprini JA, Arcelus JI, Caprini JA. Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost 1995;21(Suppl 4):53-8.
17. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, et al. Heparin and low-molecular weight heparin. Mechanisms of action, pharmacokinetics, dosing monitoring, efficacy, and safety. Chest 2001;119(Suppl):64S-94S.
18. Tuten MB, Wogt S, Dasse F, Leider Z. Utilization of prealbumin as a nutritional parameter. J Parent Enter Nutrition 1985;9:709-11.
19. Ansell J, Hirsh J, Dalen J, Bussey J, Anderson D, Poller L, Jacobson A, Deykin D, Matchar D. Managing oral anticoagulant therapy. Chest 2001;119(Suppl):22S-38S.
20. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(Suppl):8S-21S.
21. Traverso CI, Arcelus JI, Caprini JA. Role of thrombelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost 1995;21(Suppl 4):59-62.
22. Fitzgerald GA. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 1991;68(7):11B-5B.
23. Patrono C, Coller B, Dalen JE, Fitzgerald GA, Fuster V, Gent M, et al. Platelet-active drugs. The relationships among dose, effectiveness and side effects. Chest 2001;119:39S-63S.
24. Boldt J, Brosch C, Lehmann A, Haisch G, Lang J, Isgro F. Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. Ann Thorac Surg 2001;71:1524-9.
25. Lisman KA, Stetson SJ, Koerener MM, Farmer JA, Torre-Amione G. Managing heart failure with immunomodulatory agents. Cardiol Clin 2001;19:617-625.
26. Geller G, Gelber R. Pentoxifylline treatment for microangiopathic hemolytic anemia caused by mechanical heart valves. Maryland Med J 1999;48:173.
27. Frampton JE, Brogden RN. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging 1995;7:480-503.
28. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Meier P for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. N Engl J Med 2001;345:1435-43.
29. Butchart EG, Li H-H, Payne N, Buchan K, Grunkeimeier GL. Twenty years' experience with Medtronic hall valve. J Thorac Card Surg 2001;121:1090-100.
30. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501.
31. Nolan PE, Arabia FA, Smith RG, Sethi GK, Bose RK, Banchy ME, et al. Stroke outcomes following implantation of the CardioWest total artificial heart. ASAIO J 2002;48(2):145.